Predictions
Orpea Nom.
Start price
Target price
Perf. (%)
€1.32
08.09.23
08.09.23
-
08.09.24
08.09.24
10.08%
15.09.23
15.09.23
Could be very worthwhile Investment >20% year
Sartorius Stedim Biotech S.A.
Start price
Target price
Perf. (%)
€260.40
06.09.23
06.09.23
-
06.09.24
06.09.24
-23.74%
21:03
21:03
EssilorLuxottica SA
Start price
Target price
Perf. (%)
€176.96
10.08.23
10.08.23
€220.00
10.08.24
10.08.24
20.06%
20:29
20:29
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Avadel Pharmaceuticals plc ADR
Start price
Target price
Perf. (%)
€13.60
17.07.23
17.07.23
€23.00
31.12.25
31.12.25
11.03%
12.04.24
12.04.24
Could be very worthwhile Investment >20% year
Valneva SE
Start price
Target price
Perf. (%)
€6.06
11.06.23
11.06.23
€7.00
11.06.24
11.06.24
-32.66%
21:01
21:01
Could be worthwhile Investment >10% per year
Very valuable balance sheet
Virbac S.A.
Start price
Target price
Perf. (%)
€293.50
07.06.23
07.06.23
€310.00
07.06.24
07.06.24
22.77%
16.05.24
16.05.24
Could be worthwhile Investment >10% per year
Poxel S.A.
Start price
Target price
Perf. (%)
€0.61
07.06.23
07.06.23
€0.70
07.06.24
07.06.24
3.12%
16.05.24
16.05.24
Could be worthwhile Investment >10% per year
Cerenis Therapeutics Holding S.A.
Start price
Target price
Perf. (%)
€1.19
29.05.23
29.05.23
-
29.05.24
29.05.24
12.08%
11.12.23
11.12.23
Probably not worthwhile Investment
Sanofi S.A.
Start price
Target price
Perf. (%)
€95.40
23.03.23
23.03.23
€100.00
23.03.24
23.03.24
-6.93%
24.03.24
24.03.24
Could be worthwhile Investment >10% per year
Orpea Nom.
Start price
Target price
Perf. (%)
€2.58
20.02.23
20.02.23
-
20.02.24
20.02.24
-1.16%
05.03.23
05.03.23
Could be very worthwhile Investment >20% year
Orpea Nom.
Start price
Target price
Perf. (%)
€2.17
08.02.23
08.02.23
-
08.02.24
08.02.24
-9.35%
03.04.23
03.04.23
Could be very worthwhile Investment >20% year
Orpea Nom.
Start price
Target price
Perf. (%)
€2.36
07.02.23
07.02.23
€4.00
07.02.24
07.02.24
9.32%
18.02.23
18.02.23
Could be very worthwhile Investment >20% year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Orpea Nom.
Start price
Target price
Perf. (%)
€2.87
05.02.23
05.02.23
-
05.02.24
05.02.24
-10.07%
18.02.23
18.02.23
Could be very worthwhile Investment >20% year